股票/基金 实时行情 股吧

简称:太龙药业 代码:600222


会计年度:2016-12-31收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
其他12,130,528.438,382,289.163,748,239.2730.90
药品研发服务92,682,617.4027,278,945.0465,403,672.3670.57
医药流通194,551,126.40174,664,564.1319,886,562.2710.22
医药制造650,717,411.15432,505,118.68218,212,292.4733.53

会计年度:2016-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计407,882,658.02280,757,950.52127,124,707.5031.17
其他4,243,478.082,144,756.502,098,721.5849.46
药品研发服务35,860,784.388,152,251.8627,708,532.5277.27
医药流通62,253,470.8352,805,810.069,447,660.7715.18
医药制造305,524,924.73217,655,132.1087,869,792.6328.76

会计年度:2015-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计1,014,916,958.80772,424,098.63242,492,860.1723.89
其他1,255,083.51976,181.23278,902.2822.22
药品研发服务71,800,592.2622,592,801.3149,207,790.9568.53
医药流通341,829,648.89314,424,658.0327,404,990.868.02
医药制造600,031,634.14434,430,458.06165,601,176.0827.60

会计年度:2015-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计488,463,884.60382,560,423.71105,903,460.8921.68
医药流通172,169,044.05160,268,962.9511,900,081.106.91
医药研发29,161,079.206,870,019.2322,291,059.9776.44
医药制造287,133,761.35215,421,441.5371,712,319.8224.98

会计年度:2014-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计1,240,458,184.14996,747,267.45243,710,916.6919.65
医药商品流通459,799,265.88430,447,786.7429,351,479.146.38
医药制造780,658,918.26566,299,480.71214,359,437.5527.46

    3/9 转到